Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
From STAT’s Elaine Chen: Earlier this month, the FDA updated the labels of GLP-1 drugs to warn of the risk of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback